Overall Survival Benefit Up for Pyrotinib + Capecitabine in HER2-Positive Breast Cancer
Overall survival benefit demonstrated among patients with metastatic breast cancer who had received trastuzumab and taxanes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.